Positive selection of MHC class Ib-restricted CD8 + T cells on hematopoietic cells
Major histocompatibility complex (MHC) class Ib moleculesincluding H2-M3, Qa-1, Qa-2 and CD1d in mice and HLA-E, HLA-F, HLA-G and CD1a to CD1d in humans-differ from MHC class Ia molecules primarily because they have limited polymorphism 1 . Nevertheless, many MHC class Ib molecules, like MHC class Ia molecules, associate with β2-microglobulin (β2M) and present antigens to CD8 + T cells. Insight into a distinct role played by MHC class Ib was obtained with the discovery that murine H2-M3 contains a hydrophobic peptide-binding groove with a specific preference for binding N-formylated peptides 2 . Because bacteria initiate protein synthesis with N-formyl methionine and eukaryotic hosts (except for a few mitochondrial proteins) do not, it was hypothesized that MHC class Ib molecules have evolved to bind distinct microbial products for presentation to T cells 3 . Indeed, CD8 + T cells recognizing bacteria-derived N-formylated peptides presented by H2-M3 are important mediators of protective immunity against Listeria monocytogenes [4] [5] [6] . MHC class Ib-restricted CD8 + T cells specific for the antigens of a number of pathogens have been identified [7] [8] [9] [10] . For example, mice infected with Mycobacterium tuberculosis contain H2-M3-restricted CD8 + T cells 7 , whereas humans infected with M. tuberculosis contain both HLA-E- 8 and CD1-restricted cells 9, 10 . Qa-1-restricted CD8 + T cells are abundant in Salmonella typhimurium-infected mice 11 and have also been reported in L. monocytogenes-infected mice 12 . MHC class Ib-restricted CD8 + T cells differ from MHC class Ia-restricted T cells in at least four ways. First, most MHC class Ib-restricted T cells have an activated CD44 hi phenotype, even in uninfected mice 13 . Second, these cells are capable of rapidly producing interferon-γ (IFN-γ) after in vivo stimulation with anti-CD3 and have, therefore, been proposed to be an early source of IFN-γ that promotes T helper type 1 (TH1) priming 14 . Third, MHC class Ib-restricted CD8 + T cells show a peak immune response that precedes the peak response of MHC class Ia-restricted CD8 + T cells after L. monocytogenes infection 13, 15 . Fourth, these cells participate minimally in the memory response associated with a secondary challenge with L. monocytogenes 13, 15 . Thus, in many ways MHC class Ib-restricted CD8 + T cells behave like innate, rather than adaptive, effector cells.
Using K b-/-D b-/-mice that lack MHC class Ia, but express MHC class Ib, we extended the above observations and showed that MHC class Ib-restricted CD8 + T cells had an activated phenotype that was distinct from MHC class Ia-restricted CD8 + T cells. We also examined a small population of CD8 + T cells in lethally irradiated β2M -/-mice, which lack both MHC class Ia and Ib, reconstituted with wild-type bone marrow (B6 → β2M -/-chimeras). The CD8 + T cells in these chimeric mice result from positive selection, in the thymus, on MHC class I molecules expressed on hematopoietic cells 16 , whereas most CD8 + T cells require selection on thymic epithelial cells 17 . We observed that these unusual CD8 + T cells had a similar activated phenotype to MHC class Ib-restricted T cells in
These observations led us to hypothesize that MHC class Ib-restricted CD8 + T cells might be positively selected on hematopoietic cells.
We showed here that mature CD8 + thymocytes in K b-/-D b-/-mice began to express an activated phenotype immediately before they left the thymus, suggesting that this phenotype was acquired as a result of interactions in the thymus, rather than peripheral activation. Using bone marrow chimeras, we also showed that H2-M3-restricted CD8 + T cells that recognize a Listeria-derived Nformylated peptide were selected efficiently on hematopoietic cells, whereas MHC class Ia-restricted T cells were selected poorly. The ability of MHC class Ib-restricted CD8 + T cells to respond quickly to antigen may be a consequence of this unusual pattern of positive selection.
Results

MHC class Ib-restricted T cells
The majority of peripheral MHC class Ib-restricted T cells express an activated CD44 hi phenotype, even in naïve K b-/-D b-/-mice; this confirmed published data 13 ( Fig. 1a) . In contrast, most CD8 + T cells (primarily MHC class Ia-restricted) in C57BL/6 mice have a naïve CD44 int phenotype (Fig. 1a) . To investigate this difference in more detail, we examined a broad range of activation markers and showed that most peripheral MHC class Ib-restricted CD8 + T cells were β1 integrin hi β7 integrin lo CD11a hi CD122 hi Ly6C hi (Fig. 1a) . In contrast, most MHC class Ia-restricted CD8 + T cells were β1 integrin int β7 integrin hi CD11a int CD122 lo Ly6C lo (Fig. 1a) . However, MHC class Ib-and MHC class Ia-restricted CD8 + T cells expressed identical high amounts of CD62L (data not shown). In addition, CD4 + T cells in C57BL/6 and K b-/-D b-/-mice showed no marked differences in any of these activation markers (data not shown).
T cells selected on hematopoietic cells
We constructed radiation bone marrow-chimeric mice in which either C57BL/6 or β2M -/-mice were lethally irradiated and reconstituted with C57BL/6 bone marrow (B6 → B6 or B6 → β2M -/-chimeras, respectively). We observed that the small population of CD8 + T cells that developed in B6 → β2M -/-chimeras had an activated phenotype that was almost identical (Fig. 1b) to the one expressed by MHC class (Fig. 1a) ; the majority of these T cells were CD44 (Fig. 2b) . In contrast to these differences, most mature CD8 + thymocytes in both K b-/-D b-/-and C57BL/6 mice were Ly6C lo ( Fig. 2 ) and CD45RB lo (data not shown). Our observation that the majority of lymph node CD8 + T cells in K b-/-D b-/-mice expressed high amounts of Ly6C (Fig. 1a) and CD45RB (data not shown) suggested that the CD8 + cells found in the thymi of K b-/-D b-/-mice were not simply mature CD8 + T cells that were activated in the periphery and migrated back to the thymus. Instead, these data support the idea that the distinct activated phenotype of MHC class Ib-restricted T cells is due, in part, to a developmental program acquired as a consequence of their intrathymic selection.
T cell selection on hematopoietic cells
We hypothesized that the activated phenotype of mature CD4 -CD8 + thymocytes in K b-/-D b-/-mice might reflect their capacity to be positively selected on hematopoietic cells. To test this idea, we 
-/-chimeras (data not shown). Thus, although MHC class Ib-restricted CD8 + T cells seemed to develop most efficiently in mice expressing MHC class Ib on both hematopoietic cells and nonhematopoietic cells, CD8
+ T cells could also be selected in chimeras that expressed MHC class Ib only on hematopoietic cells and in chimeras that expressed these molecules only on nonhematopoietic cells.
Next, we compared the cell surface phenotypes of MHC class Ib-restricted CD8 + T cells in each of these chimeras. Like
hi (Fig. 3a) , although the percentage of CD44 + cells in β2M (Fig. 3a) .
-/-chimeras also expressed similar amounts of CD122 that were higher than the amounts expressed by CD8 + T cells in β2M (Fig. 3a) . In contrast to these differences, CD8 + T cells in both Fig. 3b) . Expansion was also seen in
controls, but the magnitude was less marked (0.6% in uninfected versus 6.1% in infected mice). β2M
-/-chimeras were also immunized with Listeria, as controls; neither showed any M3-f-MIGWII tetramer staining after infection (data not shown). Our inability to detect M3-f-MIGWII-specific CD8 + T cells in β2M -/-chimeric mice after infection with rLM-OVA. The response of OVA-specific CD8 + T cells was dominant in B6 → B6 mice compared to the f-MIGWII-specific response at day 6 after infection (Fig. 4a) . The percentage of CD8 + T cells detected with K b -OVA tetramers was consistently three-to fivefold higher than the percentage detected with M3-f-MIGWII tetramers. In contrast, OVAspecific CD8 + T cells were rare (Fig. 4a) or undetectable (data not shown) in B6 → β2M -/-chimeras, whereas f-MIGWII-specific CD8 + T cells were abundant. CD8 + T cells specific for f-MIGWII were reproducibly five-to tenfold more frequent than OVA-specific CD8 + T cells in chimeras expressing MHC class I molecules only on hematopoietic cells.
Functional studies were done to determine whether CD8 + T cells selected on hematopoietic cells were capable of producing IFN-γ and mediating cytolysis. Consistent with the frequencies observed with the use of tetramers, CD8 + T cells producing IFN-γ in response to OVA peptide were 20-fold more abundant in infected B6 → B6 chimeras than T cells responding to f-MIGWII peptide (Fig. 4b) . In contrast, B6 → β2M -/-chimeras contained at least fivefold more f-MIGWII-reactive than OVA peptide-reactive CD8 + T cells. Similarly, CD8 + T cells from infected B6 → B6 chimeras showed strong cytotoxicity against OVA peptide-loaded target cells and weak cytotoxicity against f-MIGWII-l oaded targets (Fig.  4c) , whereas CD8 + T cells from B6 → β2M -/-chimeras showed the opposite pattern: strong cytotoxicity against f-MIGWII-loaded cells and weak cytotoxicity against OVA-peptide-loaded cells. Thus, whereas most MHC class Ia-restricted thymocytes required interactions with MHC class Ia molecules on thymic epithelial cells to mature, our findings showed that functional MHC class Ib-restricted T cells were preferentially selected when MHC class I molecules were expressed only on hematopoietic cells.
Discussion
The results we present here show events that mediate the selection of MHC class Ib-restricted CD8 + T cells differ from those that mediate the selection of MHC class Ia-restricted CD8 + T cells. H2-M3-restricted CD8 + T cells are positively selected on H2-M3 molecules expressed in the thymus 21, 22 , but whether this occurs on epithelial cells or hematopoietic cells had not been examined. We show here that H2-M3-restricted CD8 + T cells are efficiently selected on hematopoietic cells, whereas MHC class Ia-restricted CD8 + T cells are poorly selected. It was shown previously that a small population of CD8 + T cells can be selected on hematopoietic cells in the thymus, and if these T cells are primed in vivo and boosted in vitro with minor histocompatibility antigens, an MHC class Ia-restricted response can be generated 16 . This seemed to suggest that CD8 + T cells selected on hematopoietic cells were not a distinct population, but represented a small subset of MHC class Ia-restricted T cells, perhaps those with relatively high affinities. However, the same rules do not seem to apply to CD4 + T cells, as selection of MHC class II-restricted T cells on hematopoietic cells has not been observed 23, 24 . In addition, some MHC class Ia-restricted CD8 + T cells in T cell receptor (TCR)-transgenic mice are unable to be positively selected on hematopoietic cells 25, 26 . Nevertheless, an example of an MHC class Ia-restricted T cell (2C, bearing a K brestricted TCR) that can be selected on hematopoietic cells has been demonstrated 26 . Initially, this finding seemed to support the idea that a subset of CD8 + T cells could be selected via interactions with MHC class Ia molecules expressed on hematopoietic cells. An alternative possibility was suggested by the subsequent finding that the 2C TCR, in addition to recognizing K b , also recognizes and can be positively selected by an MHC class Ib molecule 27 The experiments we present here were done to try to explain our finding that CD8 + T cells in K b-/-D b-/-mice and B6 → β2M
-/-chimeric mice show similar activated phenotypes. One possibility that we initially considered was that these small populations of CD8 + T cells may become activated simply as a result of proliferation that can occur in lymphopenic hosts. This explanation seemed unlikely, however, as neither population of CD8 + T cells showed much expansion, but remained at low numbers (1-3% of total spleen cells) for the lifetime of the mice. The finding that large numbers of CD4 + T cells-as are present in both K b-/-D b-/-mice and B6 → β2M -/-chimeras-inhibit, at least partially, the expansion of CD8 + T cells in hosts with small numbers of CD8 + T cells 28,29 may help to explain this lack of expansion. In addition, our observation that CD4 -CD8 + thymocytes began to express the activated phenotype in K b-/-D b-/-mice suggested that this phenotype resulted, in part, from interactions that occurred during development in the thymus, instead of expansion in the periphery.
We considered an alternative possibility, that CD8 + T cells in
-/-mice might be similar because they contained many of the same cells. We hypothesized that this would be true if MHC class Ib-restricted T cells were preferentially selected on hematopoietic cells. The presence of a population of CD8
-/-chimeric mice showed that MHC class Ib-restricted CD8 + T cells could be selected on hematopoietic cells; however, the presence of CD8 + T cells in β2M
chimeras showed that positive selection of MHC class Ib-restricted CD8 + T cells could also occur on nonhematopoietic cells, most likely thymic epithelial cells. The observation that CD8 + T cells in both
hi indicated that some components of the activated phenotype were intrinsic to MHC class Ib-restricted T cells, regardless of whether they were positively selected on hematopoietic or epithelial cells. In contrast, other markers of the activated phenotype-including expression patterns of β1 integrin, β7 integrin, CD11a and CD122-seemed to be correlated with positive selection on hematopoietic cells. Whether T cells selected on epithelial versus hematopoietic cells represented distinct subsets or whether some T cells had the capacity to be selected on either-but expressed different surface phenotypes depending upon how they were selected-was not directly addressed here. However, the finding that most CD8 + T cells in K b-/-D b-/-mice expressed the phenotype correlated with selection on hematopoietic cells suggests that this process is important for a large number of MHC class Ib-restricted CD8 + T cells. We found that MHC class Ib-restricted CD8
-/-chimeras) expressed a different set of activation markers compared to MHC class Ib-restricted CD8 + T cells that were selected on epithelial cells (in β2M
. These differences were particularly marked for integrin expression, despite that fact that most CD8 + T cells in both populations expressed an activated CD44 hi phenotype. It has been hypothesized that MHC class Ib-restricted CD8 + T cells may be a distinct subset of effector cells that functions in an immune-regulatory role 30, 31 . It seems possible that the differences in integrin expression conferred by positive selection on hematopoietic cells may alter the trafficking of these cells through lymphoid and nonlymphoid tissues, positioning them uniquely for these roles. In addition, the possibility that positive selection on hematopoietic cells functions to give MHC class Ib-restricted T cells many of their innate effector properties also needs to be addressed in future studies.
Why are MHC class Ib-restricted T cells efficiently selected on hematopoietic cells, but not MHC class Ia-restricted T cells? It is likely that the selecting ligands of many MHC class Ia-restricted T cells are expressed on hematopoietic cells and yet selection does not occur. Epithelial cells are generally believed to be specially equipped with cell-surface molecules, or cytokines, that promote T cell development, which makes them the most efficient mediators of positive selection 17 . It is possible that developing T cells with relatively high affinities for self-MHC molecules have a reduced requirement for these specialized signals. In support of this idea, CD1d-restricted natural killer T (NKT) cells-the only other T cells known to be routinely selected on hematopoietic cells [32] [33] [34] [35] [36] -are self-reactive and are believed to have higher affinities for self-MHC ligands than conventional T cells 37 . Because MHC class Ib-restricted T cells in K b-/-D b-/-have an activated phenotype in naïve mice, it seems likely that they also have relatively high affinities for self-MHC-peptide complexes. This idea is supported by the finding that a physiological ligand for positive selection of H2-M3-restricted CD8
+ T cells can function as a weak agonist for the activation of the same CD8 + T cells when they are mature 38 . As discussed above, NKT cells are the only other T cells known to be routinely selected on hematopoietic cells in the thymus [32] [33] [34] [35] [36] . NKT cells show limited TCR diversity, recognize a nonpolymorphic MHC class Ib-related molecule (CD1d), have an activated phenotype in naïve mice and participate in the early "innate" response to foreign invaders 37 . These "innate" T cells have been postulated to be evolutionary precursors of conventional T cells involved in adaptive immunity 37 
Methods
Mice. C57BL/6 and β2M -/-(backcrossed 11 times to C57BL/6 mice) mice were from Jackson Laboratories (Bar Harbor, ME). K b-/-D b-/-breeders 40 19 . The rLM-OVA was grown in BHI broth supplemented with 5 µg/ml of erythromycin. Bacteria culture samples were measured by optical density and, at the mid-log growth phase, were diluted in PBS for injection. Chimeric mice were infected with 2000 L. monocytogenes by tail-vein injection. Injected numbers (colony forming units) were more accurately determined by spreading bacterial samples on BHI plates and incubating them overnight at 37 °C. Splenocytes were collected on day 6 or 7 after infection for analysis.
Peptides and tetramers.
H-2K b tetramers bound to the OVA-derived peptide SIIN-FEKL were generated as described 43, 44 . H2-M3 tetramer bound to the Listeria-derived peptide f-MIGWII was a gift of E. Pamer (Sloan-Ketterling, New York, NY). Negative control peptides for both MHC tetramers were prepared to determine the degree of nonspecific background staining, as described 15 . Splenocytes were resuspended in PBS with fetal calf serum (5%) and NaN3 (0.1%) at a concentration of 10 7 cells/ml and stained with phycoerythrin (PE)-tetramer, allophycocyanin-anti-CD8 (clone 53.6.7, BD PharMingen, San Diego, CA) and fluorescein isothiocyanate (FITC)-anti-CD44 (clone IM7, BD PharMingen) for 1 h at 4 °C. Intracellular IFN-γ staining. Intracellular IFN-γ staining was done with a kit, as instructed by the manufacturer (Pharmingen). Briefly, in a 24-well plate, 4 × 10 6 spleen cells per well were stimulated with media alone or 10 -8 M of either OVA peptide (SIINFEKL) or f-MIGWII for 6 h in complete RPMI (RPMI 1640 supplemented with 10% fetal calf serum, 2 mM L-glutamine, 10 mM HEPES, 0.5 µM 2-mercaptoethanol, 100 U/ml of penicillin and 100 µg/ml of streptomycin) in the presence of monensin. Cells were washed, stained with allophycocyanin-anti-CD8α, resuspended in permeabilization-fixation buffer and stained with FITC-anti-IFN-γ (clone XMG1.2, Pharmingen). Labeled cells were washed in permeabilization buffer, resuspended in fix buffer and analyzed on a FACSCalibur.
CTL assay.
Splenocytes from all experimental mice were assayed ex vivo for their ability to kill peptide-loaded target cells. Serial dilutions (1:3) of effector splenocytes were done in triplicate in 96-well round-bottomed plates. Target cells (a C57BL/6-derived Rauscher leukemia virus (MuLV)-induced T cell lymphoma cell line, RMA) were labeled with 51 Cr and cultured with 10 µM OVA or f-MIGWII peptide for 1 h at 37 °C. Negative control target cells were cultured without peptide. Targets were then washed and added to effector cells at 7500 cells/well. Effector cells from each mouse were assayed separately with both peptide-loaded targets. After a 5 h incubation at 37°C , the plates were centrifuged at 1500 rpm for 5 min and cell supernatants collected. Supernatant samples (100 µl) were counted on a 1470 Wizard automatic γ counter (Perkin Elmer, Shelton, CT) to determine amount of 51 Cr release. The percent specific lysis was calculated as 100 × (experimental cpm -spontaneous cpm)/(maximum cpm -spontaneous cpm).
